Influenza Vaccine in Children With Asthma
VAGA
Evaluation of the Immunization Coverage Against Influenza in Children With Asthma Followed at the Hospital of Nancy
1 other identifier
observational
500
1 country
1
Brief Summary
The occurence of influenza can be a factor of imbalance of asthma. Asthma patients are recommended for annual influenza vaccination . However there is insufficient vaccination coverage of asthmatic patients despite this recommendation. The aim of this study is to evaluate the rate of influenza vaccination coverage of children with asthma aged from 6 month to 17 years of age followed in pediatric pneumology consultation at the university hospital of Nancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 22, 2019
CompletedFirst Posted
Study publicly available on registry
September 11, 2019
CompletedStudy Start
First participant enrolled
November 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2020
CompletedDecember 17, 2019
December 1, 2019
5 months
August 22, 2019
December 16, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of asthmatic patients vaccinated against influenza
Percentage of patients vaccinated against influenza will be evaluate among children with asthma followed in pediatric pneumology consultation.
through study completion, an average of 6 months
Secondary Outcomes (4)
Socio-demographic characteristics of patients
through study completion, an average of 6 months
Age of patients (years)
through study completion, an average of 6 months
Asthma severity (mild, moderate, severe asthma)
through study completion, an average of 6 months
Asthma symptom control (well controled, partly controlled, uncontrolled)
through study completion, an average of 6 months
Study Arms (2)
Asthmatic children vaccinated
Asthmatic children unvaccinated
Eligibility Criteria
children with asthma
You may qualify if:
- asthmatic patients followed in pediatric pneumology consultation at university hospital of Nancy aged from 6 months to 17 years
You may not qualify if:
- asthmatic children who have been followed for less than 1 year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU Nancy
Vandœuvre-lès-Nancy, 54500, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aurore Blondé, Dr
CHRU nancy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 22, 2019
First Posted
September 11, 2019
Study Start
November 4, 2019
Primary Completion
April 1, 2020
Study Completion
April 1, 2020
Last Updated
December 17, 2019
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will not share